Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes Mellitus
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The purpose of the study is to show if telemonitoring and automated feedback regarding glucose management, physical activity, blood pressure, and body weight improves treatment of patients with insulin dependent Type 2 Diabetes mellitus.
Full description
In this clinical trial 50 patients with insulin dependent type 2 diabetes will be randomised in two study arms: monitoring of blood glucose and blood pressure using a telemedical device or in an arm with treatment as usual. Patients will the following measurement devices: blood glucose, blood pressure. Both devices can communicate with a mobile phone, which will also be provided to the patients. The mobile phone will transfer the data to a central, safe server. Patients will receive automated reminder/feedback. Caregivers can evaluate the transferred data whenever necessary via a web-based access. Data will be presented in tables as well as trend figures.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Diabetes mellitus Type 2, age 18-70 years, able to use a mobile phone
Exclusion criteria
- Pacemaker, intracardial defibrillator, no cure planned within the active study period.
Trial design
Primary purpose
Allocation
Interventional model
Masking
50 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Bernhard Ludvik, MD; Karin Schindler, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal